← Every applicant
Taro FDA Approvals
21 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| LOPERAMIDE HYDROCHLORIDENew drugSep 30, 2026CAPSULE, ORAL |
| PERAMPANELNew drugJun 15, 2026SUSPENSION, ORAL |
| ACETAMINOPHEN AND IBUPROFENNew drugJan 2, 2026TABLET, ORAL |
| PERAMPANELNew drugNov 25, 2025TABLET, ORAL |
| TICAGRELORNew drugOct 28, 2025TABLET, ORAL |
| LAMOTRIGINENew drugOct 7, 2025TABLET, ORALLY DISINTEGRATING, ORAL |
| DOXEPIN HYDROCHLORIDENew drugAug 6, 2025TABLET, ORAL |
| POTASSIUM CHLORIDENew drugJul 22, 2025SOLUTION, ORAL |
| MINOXIDIL EXTRA STRENGTH (FOR MEN)New drugJun 30, 2025SOLUTION, TOPICAL |
| RIVAROXABANNew drugMar 3, 2025TABLET, ORAL |
| LACTULOSENew drugDec 13, 2024SOLUTION, ORAL |
| MINOXIDIL (FOR WOMEN)New drugNov 26, 2024SOLUTION, TOPICAL |
| PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACIDNew drugJun 28, 2024FOR SOLUTION, ORAL |
| DICLOFENAC POTASSIUMNew drugJun 14, 2024FOR SOLUTION, ORAL |
| SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATENew drugMar 19, 2024SOLUTION, ORAL |
| CLOBETASOL PROPIONATENew drugMar 14, 2024AEROSOL, FOAM, TOPICAL |
| BUMETANIDENew drugJul 24, 2023TABLET, ORAL |
| AMINOCAPROIC ACIDNew drugMar 24, 2023SOLUTION, ORAL |
| FLUPHENAZINE HYDROCHLORIDENew drugApr 14, 2022TABLET, ORAL |
| SILDENAFIL CITRATENew drugNov 16, 2021FOR SUSPENSION, ORAL |
| IMIQUIMODNew drugJan 26, 2021CREAM, TOPICAL |